Detalhe da pesquisa
1.
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging.
Eur J Nucl Med Mol Imaging
; 46(4): 821-830, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30506455
2.
Imaging αvß3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment.
Eur J Nucl Med Mol Imaging
; 45(6): 898-903, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29396636
3.
Multi-technique imaging of bone metastases: spotlight on PET-CT.
Clin Radiol
; 71(7): 620-31, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26997430
4.
Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUVmax in [18F]fluoride and [18F]FDG PET?
Mol Imaging Biol
; 21(4): 781-789, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30250989
5.
Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of 18F-Fluoride Metabolic Flux Than with Measurement of 18F-Fluoride PET/CT SUV?
J Nucl Med
; 60(3): 322-327, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042160
6.
Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment.
J Nucl Med
; 57 Suppl 1: 27S-33S, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26834098